Sunny Chapel

1.4k total citations · 1 hit paper
45 papers, 991 citations indexed

About

Sunny Chapel is a scholar working on Hematology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sunny Chapel has authored 45 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Psychiatry and Mental health and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sunny Chapel's work include Erythropoietin and Anemia Treatment (7 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Blood properties and coagulation (3 papers). Sunny Chapel is often cited by papers focused on Erythropoietin and Anemia Treatment (7 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Blood properties and coagulation (3 papers). Sunny Chapel collaborates with scholars based in United States, Germany and United Kingdom. Sunny Chapel's co-authors include Howard N. Bockbrader, Paula Burger, David Wesche, Raymond Miller, Nancy Janiczek, John A. Widness, Robert L. Schmidt, P. Veng‐Pedersen, R.J. Hohl and Richard L. Lalonde and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sunny Chapel

41 papers receiving 949 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

2010 470 citations Howard N. Bockbrader, David Wesche et al. Clinical Pharmacokinetics profile →

Peers

Countries citing papers authored by Sunny Chapel

Since Specialization

Citations

This map shows the geographic impact of Sunny Chapel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunny Chapel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunny Chapel more than expected).

Fields of papers citing papers by Sunny Chapel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunny Chapel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunny Chapel. The network helps show where Sunny Chapel may publish in the future.

Co-authorship network of co-authors of Sunny Chapel

This figure shows the co-authorship network connecting the top 25 collaborators of Sunny Chapel. A scholar is included among the top collaborators of Sunny Chapel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunny Chapel. Sunny Chapel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular Degeneration 2024 ·SHILAP Revista de lepidopterología ·Ryan L. Crass, (unknown), (unknown), Ramiro Ribeiro, Caroline R. Baumal, Brandon Smith, (unknown), Sunny Chapel	1
2	Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria 2024 ·Drugs in R&D ·Ryan L. Crass, Brandon Smith, (unknown), Sunny Chapel, Grant Langdon	0
3	Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or sham 2024 ·CPT Pharmacometrics & Systems Pharmacology ·Ryan L. Crass, (unknown), (unknown), (unknown), Ramiro Ribeiro, Sunny Chapel, Caroline R. Baumal	2
4	Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis 2023 ·Pharmaceutical Research ·Emily Briggs, Mohamed Kamal, Matthew P. Kosloski, (unknown), (unknown), (unknown), (unknown), Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Brad Shumel, Noah A. Levit, Ashish Bansal, John D. Davis, Sunny Chapel, David E. Smith, (unknown)	1
5	PB2053: POPULATION PHARMACOKINETICS OF PEGCETACOPLAN IN HEALTHY SUBJECTS AND PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2023 ·HemaSphere ·(unknown), Ryan L. Crass, Sunny Chapel, Temitayo Ajayi	1
6	Population pharmacokinetic and pharmacokinetic-pharmacodynamic modeling of bempedoic acid and low-density lipoprotein cholesterol in healthy subjects and patients with dyslipidemia 2023 ·Journal of Pharmacokinetics and Pharmacodynamics ·Satyawan Jadhav, Benny Amore, Howard N. Bockbrader, Ryan L. Crass, Sunny Chapel, William J. Sasiela, Maurice G. Emery	4
7	Population Pharmacokinetics of Vixotrigine in Healthy Volunteers and Subjects with Trigeminal Neuralgia, Painful Lumbosacral Radiculopathy and Erythromelalgia 2021 ·European Journal of Drug Metabolism and Pharmacokinetics ·Himanshu Naik, Yuan Zhao, Fiona Forrestal, Simon Cleall, Howard N. Bockbrader, Sunny Chapel	5
8	Cabozantinib exposure–response analyses of efficacy and safety in patients with advanced hepatocellular carcinoma 2019 ·Journal of Pharmacokinetics and Pharmacodynamics ·Linh T. Nguyen, Sunny Chapel, (unknown), Steven Lacy	18
9	Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis 2015 ·Clinical Therapeutics ·Sunny Chapel, (unknown), Jay Hsu, Josephine Cucchiaro, Antony Loebel	5
10	Comparison of QTc Data Analysis Methods Recommended by the ICH E14 Guidance and Exposure–Response Analysis: Case Study of a Thorough QT Study of Asenapine 2010 ·Clinical Pharmacology & Therapeutics ·Sunny Chapel, Matt Hutmacher, Howard N. Bockbrader, Rik de Greef, R L Lalonde	21
11	A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin breakdown → 2010 ·Clinical Pharmacokinetics ·Howard N. Bockbrader, David Wesche, Raymond Miller, Sunny Chapel, Nancy Janiczek, Paula Burger	470
12	Exposure‐Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation 2009 ·The Journal of Clinical Pharmacology ·Sunny Chapel, Matt Hutmacher, George M. Haig, Howard N. Bockbrader, Rik de Greef, Sheldon Preskorn, Richard L. Lalonde	47
13	Performance Characteristics for Some Typical QT Study Designs Under the ICH E‐14 Guidance 2008 ·The Journal of Clinical Pharmacology ·Matthew M. Hutmacher, Sunny Chapel, (unknown), Joseph C. Fleishaker, Richard L. Lalonde	33
14	Pharmacodynamic Analysis of the Microbiological Efficacy of Telithromycin in Patients with Community-Acquired Pneumonia 2005 ·Clinical Pharmacokinetics ·Jun Yi Shi, Marc Pfister, Stephen G. Jenkins, Sunny Chapel, Jeffrey S. Barrett, (unknown), Dan Howard	10
15	Pharmacokinetics and Safety of the Ketolide Telithromycin in Patients with Renal Impairment 2004 ·The Journal of Clinical Pharmacology ·Jun Yi Shi, Guy Montay, Sunny Chapel, Pierre Hardy, Jeffrey S. Barrett, Marshall Sack, Thomas Marbury, Suzanne K. Swan, Ramón Vargas, V. Leclerc, Bruno Leroy, Vijay O. Bhargava	32
16	Posttransfusion recovery of stored red blood cells in very low birth weight infants using a hemoglobin balance model 2004 ·Transfusion ·Anne Grete Bechensteen, Sunny Chapel, Peter Veng‐Pedersen, John A. Widness	1
17	Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy‐induced anemia and bone marrow ablation 2004 ·Biopharmaceutics & Drug Disposition ·P. Veng‐Pedersen, Sunny Chapel, Nidal Al‐Huniti, Robert L. Schmidt, (unknown), R.J. Hohl, John A. Widness	21
18	Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics 2001 ·Experimental Hematology ·Sunny Chapel, Peter Veng‐Pedersen, Robert L. Schmidt, John A. Widness	30
19	Changes in Erythropoietin Pharmacokinetics following Busulfan-Induced Bone Marrow Ablation in Sheep: Evidence for Bone Marrow as a Major Erythropoietin Elimination Pathway 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Sunny Chapel, P. Veng‐Pedersen, R.J. Hohl, Robert L. Schmidt, (unknown), John A. Widness	53
20	A Pharmacodynamic Analysis of Erythropoietin-Stimulated Reticulocyte Response in Phlebotomized Sheep 2000 ·Journal of Pharmacology and Experimental Therapeutics ·Sunny Chapel, P. Veng‐Pedersen, Robert L. Schmidt, John A. Widness	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact